FBIOP (STOCKS)
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
$13.600000
+0.030000 (+0.22%)
Prev close: $13.570000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Lindsay Allan Rosenwald
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $75.72M
- Employees
- 101
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $63.26M |
| Benefits Costs and Expenses | $96.80M |
| Cost Of Revenue | $20.92M |
| Costs And Expenses | $133.48M |
| Gross Profit | $42.34M |
| Nonoperating Income/Loss | $36.69M |
| Operating Expenses | $112.56M |
| Selling, General, and Administrative Expenses | $96.40M |
| Other Operating Expenses | $16.16M |
| Operating Income/Loss | -$70.22M |
| Income/Loss From Continuing Operations After Tax | -$32.92M |
| Income/Loss From Continuing Operations Before Tax | -$33.54M |
| Income Tax Expense/Benefit | -$620.00K |
| Net Income/Loss | -$32.92M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$39.73M |
| Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest | $39.73M |
| Net Income/Loss Attributable To Parent | $6.82M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $8.70M |
| Preferred Stock Dividends And Other Adjustments | $8.70M |
| Basic Earnings Per Share | -$0.07 |
| Diluted Earnings Per Share | -$0.07 |
| Basic Average Shares | 27,901,889 |
| Diluted Average Shares | 27,901,889 |
| Assets | $185.55M |
| Current Assets | $123.84M |
| Inventory | $9.62M |
| Other Current Assets | $114.22M |
| Noncurrent Assets | $61.71M |
| Fixed Assets | $2.52M |
| Other Non-current Assets | $59.19M |
| Liabilities | $123.37M |
| Current Liabilities | $49.74M |
| Accounts Payable | $14.24M |
| Other Current Liabilities | $35.51M |
| Noncurrent Liabilities | $73.62M |
| Long-term Debt | $52.42M |
| Other Non-current Liabilities | $21.20M |
| Equity | $62.18M |
| Equity Attributable To Noncontrolling Interest | $12.31M |
| Equity Attributable To Parent | $49.87M |
| Liabilities And Equity | $185.55M |
| Net Cash Flow From Operating Activities | -$65.78M |
| Net Cash Flow From Operating Activities, Continuing | -$65.78M |
| Net Cash Flow From Investing Activities | $10.12M |
| Net Cash Flow From Investing Activities, Continuing | $10.12M |
| Net Cash Flow From Financing Activities | $77.44M |
| Net Cash Flow From Financing Activities, Continuing | $77.44M |
| Net Cash Flow | $21.79M |
| Net Cash Flow, Continuing | $21.79M |
| Comprehensive Income/Loss | -$32.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$32.92M |
| Other Comprehensive Income/Loss | $0.00 |